Experience

Genome Atlantic

• Canada
• Research Services
• 1 - 100 Employee

• Associate, Sector Innovation

  • Dec 2020 - Present

  - Supporting opportunity generation pipeline and business development strategy - Focus on translational strategy and articulating the stepwise process for end-users to realize the expected socio-economic benefits to Canada - explain the partnerships, business models and processes needed for GE3LS (Genomics and its Ethical, Environmental, Economic, Legal and Social Aspects) to mitigate downstream risks that may be encountered during implementation of the ‘omics technology being developed in the grant Show less



Sanbonki Inc.

• Greater Toronto Area

• President

  • Oct 2011 - Present

  - Consulting assignments positioning companies for investment, partnerships and value growth - Guiding organizations to create greater value - Successfully positioned the business cases for millions of dollars of development projects for government grants - Strategic advisory on product licensing, management coaching and implementation, corporate turnarounds, operational efficiency, due diligence, exit strategy - Consulting assignments positioning companies for investment, partnerships and value growth - Guiding organizations to create greater value - Successfully positioned the business cases for millions of dollars of development projects for government grants - Strategic advisory on product licensing, management coaching and implementation, corporate turnarounds, operational efficiency, due diligence, exit strategy



Andrew Yoshioka Management Consulting

• President

  • Sep 2010 - Oct 2011

  Pharma/Biotech Management Consulting Pharma/Biotech Management Consulting



YM BioSciences

• Canada
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• • Jul 2009 - Aug 2010

  Led global AeroLEF program and business development activities to derive maximum revenue from potential partners. Managed technical data continuity, partnering due diligence activities, program legacy and clinical program deliverables. Developed strategic documents, development plan, business and clinical documentation, commercial value proposition.

• • Sep 2008 - Jul 2009

  Developed clinical strategy and clinical development plan in support of the out-licensing mandate. Provided overall project continuity and leadership of clinician consultants. Presented clinical data and clinical development plan at EU regulatory agency and key opinion leader consultations and partnering meetings. Authored key clinical documents such as Investigator Brochure, clinical study reports, clinical protocols, clinical development plan, clinical data reviews, regulatory agency briefing documents. Contributed to development of key partnering documentation, pricing and reimbursement strategy, target product profile. Show less

• • Oct 2006 - Sep 2008

  Developed marketing strategy and business development plan for company products, maintained oversight of strategic product profiles for licensing. Contributed commercial input to project teams and product development planning, product positioning, value propositions, key messaging, publication strategy, medical conference planning, KOL development, sales forecasts, market research planning



DELEX Therapeutics

• Director of Product Development

  • Jul 2001 - Oct 2006

  Post-YM merger, executed clinical development plan for lead compound, including negotiation of contracts with CROs. Pre-YM merger, supported due diligence activities with strategic partners. Directed a clinical, regulatory and quality team through successful Phase 1 and Phase 2 CTA/IND approvals from Health Canada post-Series B startup financing. Developed, refined and executed efficient preclinical, clinical development and regulatory strategic plans with corporate management team responsibilities for product development. Negotiated contracts and managed CROs to successful completion of product development projects. Presented overall product development plans and supported due diligence activities with venture capital investors and strategic partners. Led multifunctional teams of consultants through pre-IND meetings with Health Canada and FDA. Show less



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• • Jan 2001 - Jun 2001

• • Mar 1998 - Dec 2000

  Lead internal preparations and brand development for Avandia pre-launch, through diabetes KOL development. Performed situation analysis and developed an initial marketing and training plan and budget. Established SB Pharma as a leader in the diabetes community through National Diabetes Surveillance System partnership, Canadian Diabetes Association professional conference, public relations and advocacy initiatives, from a baseline where the company was not known in the diabetes therapeutic field. Show less



Bencard Allergy Laboratories (SmithKline Beecham)

• General Manager

  • Nov 1996 - Jun 1998

  Initiated business review and revitalization plan including manufacturing and system upgrades of a GMP sterile pharmaceutical product manufacturing, importation, distribution and sales franchise. Investigated GMP product quality issues and implemented process improvements to restart manufacturing operations. Created analytical systems to determine most profitable product and customer segments, leading to rationalization of the allergy and diagnostics product portfolio and customer base. Developed long range business recommendations. Managed headcount of 15-25 staff through periods of manufacturing shutdown and layoffs, business revitalization, recruitment of 5 new staff, and franchise divestiture to global management buyout team. Successfully implemented Canadian component of worldwide franchise due diligence and divestiture. Delivered profit targets leading up to the sale of the franchise. Show less



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• • Jan 1995 - Nov 1996

  Planned, developed product positioning and executed launch plans for new indication. Prepared and submitted long range strategic plan. Transferred product knowledge, implemented and monitored marketing launch plan following the execution of all regulatory activities leading to product approval.

• • Mar 1993 - Jan 1995

  Responsible for preparation of Electronic New Drug Submission and other types of regulatory submissions. Regulatory affairs activities associated with achievement of anti-infective product approvals. Review of marketing promotional materials.



Boehringer Ingelheim (Canada) Ltd.

• • Jan 1992 - Mar 1993

  Responsible for regulatory activities for cardiovascular and respiratory products. Participated on clinical trial protocol development teams. Reviewed marketing dockets and released clinical trial supply shipments. Prepared provincial formulary reimbursement submissions.

• • Feb 1991 - Dec 1991

• • May 1989 - May 1991

  Covered two overlapping maternity leave assignments to follow-up and report adverse events to Health Canada and corporate Drug Regulatory Affairs. Supervised preparation and randomization of clinical trial supplies. Collected and summarized literature for product information requests from external and internal inquiries. Reviewed marketing dockets. Monitored clinical trials to GCP standards. Developed case report forms. Participated on protocol development and Phase 1 clinical trials harmonization teams. Show less

• • Jul 1985 - May 1989

  Promoted cardiovascular, gastrointestinal and anti-infective products to physicians and pharmacists in clinics, teaching hospitals and retail pharmacies.